Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok® Influenza Vaccine

July 8, 2014 Protein Sciences Corporation announced today that the FDA has approved the Company’s strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season’s manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will …